Organization
University of Michigan Rogel Comprehensive Cancer Center
7 abstracts
Abstract
Safety and clinical activity of TTI-621 in combination with doxorubicin in patients with unresectable or metastatic high-grade leiomyosarcoma: Results from the low-dose expansion cohort.Org: Memorial Sloan Kettering Cancer Center, Knight Cancer Institute, University of Iowa Carver College of Medicine, University of Michigan Rogel Comprehensive Cancer Center, Sarcoma Oncology Center,
Abstract
Lete-cel in patients with synovial sarcoma or myxoid/round cell liposarcoma: Planned interim analysis of the pivotal IGNYTE-ESO trial.Org: Memorial Sloan Kettering Cancer Center, Royal Marsden NHS Foundation Trust, The Christie NHS Foundation Trust and University of Manchester, University of Pittsburgh Medical Center (UPMC), Duke Cancer Institute,
Abstract
Phase 1/1b study of SY-5609, a selective and potent CDK7 inhibitor, in advanced solid tumors and in 2L/3L pancreatic ductal adenocarcinoma (PDAC) in combination with gemcitabine +/- nab-paclitaxel.Org: Sarah Cannon Research Institute and Sidney Kimmel Cancer Center, Thomas Jefferson University, Thomas Jefferson University, START Midwest, Grand Rapids, MI, Massachusetts General Hospital Cancer Center, Surgical Oncology, Boston, MA, START San Antonio,
Abstract
Long-term outcomes of pembrolizumab (pembro) in combination with gemcitabine (gem) and concurrent hypofractionated radiation therapy (RT) as bladder sparing treatment for muscle-invasive urothelial cancer of the bladder (MIUC): A multicenter phase 2 trial.Org: UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, University of Chicago Comprehensive Cancer Center, Chicago, IL, University of Michigan Rogel Comprehensive Cancer Center, Memorial Sloan Kettering Cancer Center, Lineberger Comprehensive Cancer Center,
Abstract
SARC037: Results of phase I study of trabectedin given as a 1-hour (h) infusion in combination with low dose irinotecan in relapsed/refractory Ewing sarcoma (ES).Org: Children's Hospital of Philadelphia, Weill Cornell Medicine and NewYork-Presbyterian Hospital, New York, NY, Pediatric Oncology Branch, Clinical Center National Institutes of Health, Clinical Center National Institutes of Health, NIH / NCI,
Abstract
Variations in the approach to lung metastases in osteosarcoma among pediatric and adult patients.Org: Department of Internal Medicine, University of Michigan, Rogel Cancer Center, University of Michigan, Ann Arbor, MI, Michigan Medicine, Rogel Cancer Center, University of Michigan, Ann Arbor, MI, Department of Surgery, University of Michigan,
Abstract
Risk of severe toxicity from topical fluoropyrimidine treatment in patients carrying DPYD variant alleles.Org: University of Michigan, University of Michigan Rogel Comprehensive Cancer Center, University of Michigan College of Pharmacy,